Filing Details

Accession Number:
0001567619-22-016958
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-09-01 19:04:04
Reporting Period:
2022-08-31
Accepted Time:
2022-09-01 19:04:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1437402 Ardelyx Inc. ARDX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1466562 A Justin Renz C/O Ardelyx, Inc.
400 Fifth Avenue, Suite 210
Waltham MA 02451
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-08-31 3,000 $0.62 263,549 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. Reflects the adjusted total which includes the purchase of 3,000 shares under the Ardelyx Employee Stock Purchase Plan on August 31, 2022.